Salivary biomarkers Levels In SARS CoV2 Positive Individuals â?? An Observational Study
Not Applicable
- Registration Number
- CTRI/2022/12/048563
- Lead Sponsor
- Dr Vandana S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Subjects aged between 19-45 yrs with positive COVID 19 history and a positive RT-PCR report taken 6 months back.
Exclusion Criteria
1.Patients with history of potentially malignant disorder or any cancer
2.History of any recent viral infection
3.Patients with history of tobacco consumption (smoke or smokeless)
4.Patient with chronic inflammatory diseses such as tuberculosis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What role do cyclin-dependent kinases play in SARS-CoV-2 pathogenesis as studied in CTRI/2022/12/048563?
How do salivary protein carbonyl levels correlate with disease severity in SARS-CoV-2 patients?
Are CDK inhibitors or antioxidants being explored as therapeutic strategies for SARS-CoV-2-related oxidative stress?
Which salivary biomarkers predict response to antiviral therapies in SARS-CoV-2-positive individuals?
What adverse events are associated with elevated CDK activity in SARS-CoV-2 observational studies?